• Latest
Drugmakers yet to see gains from government’s minimum import price policy

Drugmakers yet to see gains from government’s minimum import price policy

June 23, 2026

Ridon dares Sara Duterte to attend Monday’s impeachment trial

September 12, 2026

9/11 at 25: How the ‘War on Terror’ helped mainstream Europe’s far right | Opinions

September 12, 2026

Stranger’s act of kindness leaves Singapore mum touched after he carries injured child to clinic

September 12, 2026

Railway Department issues special notice

September 12, 2026

Sending troops to Ukraine means…: Putin’s warning to Europe

September 12, 2026

Congress’ Manish Tewari as New Delhi gears up to host BRICS Summit

September 12, 2026

One-day awareness session on WASH issues held

September 12, 2026

TOYO identifies gas chemicals, fertilizers as key areas in Turkmenistan (Exclusive)

September 12, 2026

Israeli demolitions threaten schools and homes in Masafer Yatta | Israel-Palestine conflict News

September 12, 2026

DFA: China’s ‘island-building’ can’t erase PH rights over reefs

September 12, 2026

Jerusalem highlights: September 11-17 | The Jerusalem Post

September 12, 2026

Playing it SAF and fair for our athletes

September 12, 2026
Saturday, September 12, 2026
  • About us
  • Advertise with us
  • Submit Articles
  • Privacy Policy
  • Contact us
Asia Today
No Result
View All Result
Subscribe
  • Login
  • Eastern Asia
    • China
    • Japan
    • Mongolia
    • North Korea
    • South Korea
  • South-eastern Asia
    • Brunei
    • Cambodia
    • Indonesia
    • Laos
    • Malaysia
    • Myanmar
    • Philippines
    • Singapore
    • Thailand
    • Timor Leste
    • Vietnam
  • Southern Asia
    • Afghanistan
    • Bangladesh
    • Bhutan
    • India
    • Iran
    • Maldives
    • Nepal
    • Pakistan
    • Sri Lanka
  • Central Asia
    • Kazakhstan
    • Kyrgyzstan
    • Tajikistan
    • Turkmenistan
    • Uzbekistan
  • Western Asia
    • Armenia
    • Azerbaijan
    • Bahrain
    • Cyprus
    • Georgia
    • Iraq
    • Israel
    • Jordan
    • Kuwait
    • Lebanon
    • Oman
    • Qatar
    • Saudi Arabia
    • State of Palestine
    • Syria
    • Turkey
    • United Arab Emirates
    • Yemen
  • More News
    • Opinion
    • Politics
    • Business
    • Entertainment
    • Fashion
    • Food
    • Health
    • Lifestyle
    • Science
    • Tech
    • Sports
  • Eastern Asia
    • China
    • Japan
    • Mongolia
    • North Korea
    • South Korea
  • South-eastern Asia
    • Brunei
    • Cambodia
    • Indonesia
    • Laos
    • Malaysia
    • Myanmar
    • Philippines
    • Singapore
    • Thailand
    • Timor Leste
    • Vietnam
  • Southern Asia
    • Afghanistan
    • Bangladesh
    • Bhutan
    • India
    • Iran
    • Maldives
    • Nepal
    • Pakistan
    • Sri Lanka
  • Central Asia
    • Kazakhstan
    • Kyrgyzstan
    • Tajikistan
    • Turkmenistan
    • Uzbekistan
  • Western Asia
    • Armenia
    • Azerbaijan
    • Bahrain
    • Cyprus
    • Georgia
    • Iraq
    • Israel
    • Jordan
    • Kuwait
    • Lebanon
    • Oman
    • Qatar
    • Saudi Arabia
    • State of Palestine
    • Syria
    • Turkey
    • United Arab Emirates
    • Yemen
  • More News
    • Opinion
    • Politics
    • Business
    • Entertainment
    • Fashion
    • Food
    • Health
    • Lifestyle
    • Science
    • Tech
    • Sports
No Result
View All Result
Morning News
No Result
View All Result
Home Health

Drugmakers yet to see gains from government’s minimum import price policy

by Asia Today Team
June 23, 2026
in Health
Reading Time: 2 mins read
21 0
A A
0
Drugmakers yet to see gains from government’s minimum import price policy
25
SHARES
307
VIEWS
Share on FacebookShare on Twitter

READ ALSO

Centre may provide 100% funding support for medical testing equipment, says Piyush Goyal

Doc Talk | Is It Swine Flu, COVID-19, or a Common Cold? A Doctor’s Guide to Identifying the Differences


New Delhi: The federal government’s efforts to assist indigenous drug makers by means of the Minimal Import Worth (MIP) framework is but to see a transparent useful impression, a number of trade executives advised ET. Earlier this 12 months the federal government had restricted home pharmaceutical corporations from importing a couple of key uncooked supplies beneath a threshold pricing.

The MIP was set for some key pharmaceutical inputs like penicillin G and its salts, 6 APA and amoxicillin. In line with the notification from the Directorate Basic of Overseas Commerce (DGFT), the import worth for penicillin, a key uncooked materials for antibiotics, was set at ₹2,216 per kg, for amoxicillin the import worth was fastened at ₹2,733 per kg and ₹3,405 per kg for 6-APA.

Additionally Learn: Stress, poor sleep and processed meals are driving coronary heart assaults in younger Indians: Ramakanta Panda

“Demand is but to return and that raises considerations concerning the effectiveness of a coverage to bolster home pharmaceutical manufacturing,” one senior government advised ET. He added that the federal government’s clear intent to strengthen the Make in India agenda by means of the MIP mechanism has not discovered the anticipated traction from consumers, merchants, and completed dosage kind (FDF) producers who’ve been gradual or reluctant to pivot towards home suppliers at MIP linked costs.

“Because of this, a major put in capability is mendacity underutilised,” he added.

ET logo

Reside Occasions


Additionally Learn: India bans 16 fixed-dose drug mixtures over security considerations

Nonetheless, others say that it is a passing section. “Many consumers had stocked up closely on a couple of uncooked supplies in anticipation of MIP kicking in, and that could possibly be one of many causes for the lukewarm response,” he famous.He added he’s hopeful that the stockpiles at the moment are regularly being consumed and as soon as they run out, consumers will supply contemporary materials.

“We acquired the MIP in September 2025, pre-war, and until date we’ve low volumes regardless of having double the capability India wants. MIP on ATS-8 fully debunks the parable of demand and provide,” mentioned Namit Joshi, chairman, Pharmexcil.



Source link

Tags: drugmakersGainsGOVERNMENTSimportMinimumpolicyprice

Related Posts

Health

Centre may provide 100% funding support for medical testing equipment, says Piyush Goyal

September 8, 2026
Health

Doc Talk | Is It Swine Flu, COVID-19, or a Common Cold? A Doctor’s Guide to Identifying the Differences

September 7, 2026
Health

AI Tools from IIT Madras and CMC Vellore, ETHealthworld

September 9, 2026
Health

BCCI Takes Major Action As 62 Players Caught In Age Fraud

September 12, 2026
Health

How To Protect Workers During Hot Road Projects

September 5, 2026
Health

Monsoon illnesses & flu surge lift drug demand

September 3, 2026
Asia Today

Copyright © 2022 Asia Today.

Navigate Site

  • Disclaimer
  • Privacy Policy
  • Cookie Privacy Policy
  • DMCA
  • Terms and Conditions
  • Contact us

Follow Us

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
  • World
  • Eastern Asia
    • China
    • Japan
    • Mongolia
    • North Korea
    • South Korea
  • South-eastern Asia
    • Brunei
    • Cambodia
    • Indonesia
    • Laos
    • Malaysia
    • Myanmar
    • Philippines
    • Singapore
    • Thailand
    • Timor Leste
    • Vietnam
  • Southern Asia
    • Afghanistan
    • Sri Lanka
    • Bangladesh
    • Bhutan
    • India
    • Iran
    • Maldives
    • Nepal
    • Pakistan
    • Central Asia
    • Kazakhstan
    • Kyrgyzstan
    • Tajikistan
    • Turkmenistan
    • Uzbekistan
  • Western Asia
    • Armenia
    • Azerbaijan
    • Bahrain
    • Cyprus
    • Georgia
    • Iraq
    • Israel
    • Jordan
    • Kuwait
    • Lebanon
    • Oman
    • Qatar
    • Saudi Arabia
    • State of Palestine
    • Syria
    • Turkey
    • United Arab Emirates
    • Yemen
  • Opinion
  • Politics
  • Business
  • Entertainment
  • Fashion
  • Food
  • Health
  • Lifestyle
  • Science
  • Tech
  • Travel
  • Sports
  • About us
  • Advertise with us
  • Privacy Policy
  • Contact us
  • Support AsiaToday

Copyright © 2022 Asia Today.